These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 5262425)

  • 1. Frequency of rubella antibody in Puerto Rican adults.
    Méndez Cashion D; Sever JL; Nazario R; Gilkeson MR
    Bol Asoc Med P R; 1969 Nov; 61(11):406-8. PubMed ID: 5262425
    [No Abstract]   [Full Text] [Related]  

  • 2. Medical practices for prevention of perinatal infections in Puerto Rico.
    Dayan GH; Caquías CR; García Y; Malik T; Copeland J; Bi D; Reef S
    Paediatr Perinat Epidemiol; 2008 Jan; 22(1):31-9. PubMed ID: 18173782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rubella susceptibility among Puerto Rican mothers.
    Greenberg ER; Blake PA; Cline BL; Hermann KL
    Bol Asoc Med P R; 1974 Nov; 65(11):259-61. PubMed ID: 4531916
    [No Abstract]   [Full Text] [Related]  

  • 4. Rubella among Puerto Rican basic trainees.
    Vaeth SJ
    Mil Med; 1977 Jul; 142(7):539-41. PubMed ID: 407506
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Factors associated with low immunity to rubella infection on antenatal screening.
    Francis B; Thomas A; Haverkamp M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):172. PubMed ID: 16638048
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: seroepidemiology study of rubella antibodies among pregnant women from seven Asian countries: evaluation of the rubella vaccination program in Taiwan.
    Arya SC; Agarwal N
    Vaccine; 2006 Nov; 24(49-50):7023. PubMed ID: 16949183
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence of rubella antibodies among schoolgirls in Sana'a, Republic of Yemen.
    Sallam TA; Raja'a YA; Benbrake MS; Al-Shaibani KS; Al-Hababi AA
    East Mediterr Health J; 2003; 9(1-2):148-51. PubMed ID: 15562744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rubella antibodies in normal pregnant women at Srinagarind Hospital, Khon Kaen, Thailand.
    Boonruang S; Buppasiri P
    J Med Assoc Thai; 2005 Apr; 88(4):455-9. PubMed ID: 16146247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunity and anti-rubella vaccination].
    Delville JP; Tellini-Emma M
    Arch Belg Med Soc; 1970 May; 28(5):321-30. PubMed ID: 5494764
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost effectiveness of prevaccination screening of health care workers for immunity to measles, rubella and mumps.
    Ferson MJ; Robertson PW; Whybin LR
    Med J Aust; 1994 Apr; 160(8):478-82. PubMed ID: 8170422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles--Puerto Rico, 1993, and the measles elimination program.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Mar; 43(9):171-3. PubMed ID: 8164642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of rubella antibodies following natural infection.
    Dunlevy M
    J Ir Med Assoc; 1974 Mar; 67(5):127-9. PubMed ID: 4815647
    [No Abstract]   [Full Text] [Related]  

  • 13. [Problems of mass vaccination against rubella].
    Just M; Bürgin-Wolff A; Frutiger U; Ritzel G
    Schweiz Med Wochenschr; 1969 Jun; 99(26):953-5. PubMed ID: 5802005
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
    Janaszek-Seydlitz W; Bucholc B; Wysokińska T; Górska P; Gniadek G
    Przegl Epidemiol; 2003; 57(2):281-8. PubMed ID: 12910596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinguishing between primary infection and reinfection with rubella vaccine virus by IgG avidity assay in pregnant women.
    Hamkar R; Jalilvand S; Abdolbaghi MH; Jelyani KN; Esteghamati A; Hagh-goo A; Mohktari-Azad T; Nategh R
    East Mediterr Health J; 2009; 15(1):94-103. PubMed ID: 19469431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with low immunity to rubella infection on antenatal screening.
    Sathanandan D; Gupta L; Liu B; Rutherford A; Lane J
    Aust N Z J Obstet Gynaecol; 2005 Oct; 45(5):435-8. PubMed ID: 16171483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rubella eradication: the countdown begins.
    Irons B
    West Indian Med J; 1998 Sep; 47(3):75-6. PubMed ID: 9861854
    [No Abstract]   [Full Text] [Related]  

  • 18. Artificial challenge studies in rubella. Utilization of RA 27-3 rubella vaccines, rubella naturally acquired seropositives, and rubella susceptible children.
    Naficy K; Nategh R; Ahangary S; Mohsenin H
    Am J Dis Child; 1970 Dec; 120(6):520-3. PubMed ID: 5481902
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rubella vaccination program in Brittany (1971-1975)].
    Senecal J; Zourbas J; Morvan A; Roussey A
    Ann Pediatr (Paris); 1976 Feb; 23(2):105-9. PubMed ID: 16104237
    [No Abstract]   [Full Text] [Related]  

  • 20. Rubella immunity levels in the United States population: has the threshold of viral elimination been reached?
    Hyde TB; Kruszon-Moran D; McQuillan GM; Cossen C; Forghani B; Reef SE
    Clin Infect Dis; 2006 Nov; 43 Suppl 3():S146-50. PubMed ID: 16998774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.